News
HSA Adverse Drug Reaction News 2019 May, Vol.21 No.1
Professionals
Allied Health Professionals
Dental Practitioners
Doctors
Nurses
Pharmacists
TCM Practitioners
6 May 2019
Access and read HSA's May 2019 bulletin which covers adverse events for health products and other news.
HSA Adverse Drug Reaction News 2019 May, Vol.21 No.1
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
Recall of three brands of losartan products found to contain N-nitroso-N-methyl-4-aminobutyric (NMBA)
Fluoroquinolones and aortic aneurysm and dissection
Update on the recent study findings on the risk of non-melanoma skin cancer with prolonged use of hydrochlorothiazide
Analysis of adverse event reports for the year 2018
AE Case in Focus: Test Yourself
List of Dear Healthcare Professional Letters (1 Dec 2018 – 30 April 2019)
Sodium-glucose cotransporter 2 inhibitors and risk of necrotising fasciitis of the perineum (Fournier’s gangrene)